Bill
Bill > H1121
summary
Introduced
03/29/2021
03/29/2021
In Committee
03/29/2021
03/29/2021
Crossed Over
Passed
Dead
12/31/2022
12/31/2022
Introduced Session
192nd General Court
Bill Summary
Relative to maximum allowable costs lists utilized by payers and pharmaceutical benefit managers to identify the maximum amount health plans will pay for certain prescription drugs. Financial Services.
AI Summary
This bill establishes a special commission to investigate the use of maximum allowable costs (MAC) lists by payers and pharmaceutical benefit managers (PBMs) to determine the maximum amount health plans will pay for certain prescription drugs. The commission will review current practices surrounding the determination and use of MAC lists, including their financial implications, industry-wide standardization, and transparency in the development and utilization processes. The commission will consist of 10 members, including representatives from the government, healthcare industry, and advocacy groups. The commission is required to submit a report with its findings and any recommended legislation within 180 days of the bill's passage.
Committee Categories
Business and Industry
Sponsors (7)
Brad Jones (R)*,
Angelo D'Emilia (R),
Paul Frost (R),
Susan Gifford (R),
Steven Howitt (R),
Hannah Kane (R),
Matt Muratore (R),
Last Action
Accompanied a study order, see H4975 (on 09/01/2022)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/192/H1121 |
| Bill | https://malegislature.gov/Bills/192/H1121.pdf |
Loading...